Stay updated on Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedA new publication reference was added under Publications, citing a 2026 online-ahead-of-print article by Paller et al. on clinical laboratory parameters in adolescents with moderate-to-severe atopic dermatitis treated with tralokinumab in ECZTRA 6. This entry expands the study's related literature linked to ECZTRA 6.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page’s displayed software/site release revision is updated from v3.5.2 to v3.5.3 at the bottom of the page, indicating a minor platform/version change rather than any change to the trial information.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a backend release update with no user-facing changes to study details.SummaryDifference0.0%

- Check52 days agoChange Detected- Revision tag updated from v3.4.2 to v3.4.3; this update does not alter study details or user-facing content.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 removed; these are site versioning updates and do not affect the trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.